Haslett, K, Blackhall, F, Koh, P, Asselin, M-C, Jackson, A, Manoharan, P, Ryder, W D, Taylor, B & Faivre-Finn, C 2018, Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC . in Radiotherapy and Oncology . vol. 127, PO-0753, pp. S387-S387 . https://doi.org/10.1016/j.jtho.2017.09.620